Comprehensive DNA Methylation and Mutation Analyses Reveal a Methylation Signature in Colorectal Sessile Serrated Adenomas

Árpád V. Patai, Barbara Kinga Barták, Bálint Péterfia, Tamás Micsik, Réka Horváth, Csaba Sumánszki, Zoltán Péter, Árpád Patai, Gábor Valcz, Alexandra Kalmár, Kinga Tóth, T. Krenács, Z. Tulassay, B. Molnár

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Colorectal sessile serrated adenomas (SSA) are hypothesized to be precursor lesions of an alternative, serrated pathway of colorectal cancer, abundant in genes with aberrant promoter DNA hypermethylation. In our present pilot study, we explored DNA methylation profiles and examined selected gene mutations in SSA. Biopsy samples from patients undergoing screening colonoscopy were obtained during endoscopic examination. After DNA isolation and quality analysis, SSAs (n = 4) and healthy controls (n = 5) were chosen for further analysis. DNA methylation status of 96 candidate genes was screened by q(RT)PCR using Methyl-Profiler PCR array system. Amplicons for 12 gene mutations were sequenced by GS Junior Instrument using ligated and barcoded adaptors. Analysis of DNA methylation revealed 9 hypermethylated genes in both normal and SSA samples. 12 genes (CALCA, DKK2, GALR2, OPCML, PCDH10, SFRP1, SFRP2, SLIT3, SST, TAC1, VIM, WIF1) were hypermethylated in all SSAs and 2 additional genes (BNC1 and PDLIM4) were hypermethylated in 3 out of 4 SSAs, but in none of the normal samples. 2 SSAs exhibited BRAF mutation and synchronous MLH1 hypermethylation and were microsatellite instable by immunohistochemical analysis. Our combined mutation and DNA methylation analysis revealed that there is a common DNA methylation signature present in pre-neoplastic SSAs. This study advocates for the use of DNA methylation as a potential biomarker for the detection of SSA; however, further investigation is needed to better characterize the molecular background of these newly recognized colorectal lesions.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalPathology and Oncology Research
DOIs
Publication statusAccepted/In press - Nov 29 2016

Fingerprint

DNA Methylation
Adenoma
Methylation
Mutation
Genes
Polymerase Chain Reaction
DNA
Colonoscopy
Microsatellite Repeats
Colorectal Neoplasms
Biomarkers
Biopsy

Keywords

  • Biomarker
  • DNA methylation
  • Mutation
  • Serrated polyp
  • Sessile serrated adenoma
  • Traditional serrated adenoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Oncology
  • Cancer Research

Cite this

Comprehensive DNA Methylation and Mutation Analyses Reveal a Methylation Signature in Colorectal Sessile Serrated Adenomas. / Patai, Árpád V.; Barták, Barbara Kinga; Péterfia, Bálint; Micsik, Tamás; Horváth, Réka; Sumánszki, Csaba; Péter, Zoltán; Patai, Árpád; Valcz, Gábor; Kalmár, Alexandra; Tóth, Kinga; Krenács, T.; Tulassay, Z.; Molnár, B.

In: Pathology and Oncology Research, 29.11.2016, p. 1-6.

Research output: Contribution to journalArticle

Patai, Árpád V. ; Barták, Barbara Kinga ; Péterfia, Bálint ; Micsik, Tamás ; Horváth, Réka ; Sumánszki, Csaba ; Péter, Zoltán ; Patai, Árpád ; Valcz, Gábor ; Kalmár, Alexandra ; Tóth, Kinga ; Krenács, T. ; Tulassay, Z. ; Molnár, B. / Comprehensive DNA Methylation and Mutation Analyses Reveal a Methylation Signature in Colorectal Sessile Serrated Adenomas. In: Pathology and Oncology Research. 2016 ; pp. 1-6.
@article{5a158c07789d44a69755b17dc21af177,
title = "Comprehensive DNA Methylation and Mutation Analyses Reveal a Methylation Signature in Colorectal Sessile Serrated Adenomas",
abstract = "Colorectal sessile serrated adenomas (SSA) are hypothesized to be precursor lesions of an alternative, serrated pathway of colorectal cancer, abundant in genes with aberrant promoter DNA hypermethylation. In our present pilot study, we explored DNA methylation profiles and examined selected gene mutations in SSA. Biopsy samples from patients undergoing screening colonoscopy were obtained during endoscopic examination. After DNA isolation and quality analysis, SSAs (n = 4) and healthy controls (n = 5) were chosen for further analysis. DNA methylation status of 96 candidate genes was screened by q(RT)PCR using Methyl-Profiler PCR array system. Amplicons for 12 gene mutations were sequenced by GS Junior Instrument using ligated and barcoded adaptors. Analysis of DNA methylation revealed 9 hypermethylated genes in both normal and SSA samples. 12 genes (CALCA, DKK2, GALR2, OPCML, PCDH10, SFRP1, SFRP2, SLIT3, SST, TAC1, VIM, WIF1) were hypermethylated in all SSAs and 2 additional genes (BNC1 and PDLIM4) were hypermethylated in 3 out of 4 SSAs, but in none of the normal samples. 2 SSAs exhibited BRAF mutation and synchronous MLH1 hypermethylation and were microsatellite instable by immunohistochemical analysis. Our combined mutation and DNA methylation analysis revealed that there is a common DNA methylation signature present in pre-neoplastic SSAs. This study advocates for the use of DNA methylation as a potential biomarker for the detection of SSA; however, further investigation is needed to better characterize the molecular background of these newly recognized colorectal lesions.",
keywords = "Biomarker, DNA methylation, Mutation, Serrated polyp, Sessile serrated adenoma, Traditional serrated adenoma",
author = "Patai, {{\'A}rp{\'a}d V.} and Bart{\'a}k, {Barbara Kinga} and B{\'a}lint P{\'e}terfia and Tam{\'a}s Micsik and R{\'e}ka Horv{\'a}th and Csaba Sum{\'a}nszki and Zolt{\'a}n P{\'e}ter and {\'A}rp{\'a}d Patai and G{\'a}bor Valcz and Alexandra Kalm{\'a}r and Kinga T{\'o}th and T. Kren{\'a}cs and Z. Tulassay and B. Moln{\'a}r",
year = "2016",
month = "11",
day = "29",
doi = "10.1007/s12253-016-0154-6",
language = "English",
pages = "1--6",
journal = "Pathology and Oncology Research",
issn = "1219-4956",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Comprehensive DNA Methylation and Mutation Analyses Reveal a Methylation Signature in Colorectal Sessile Serrated Adenomas

AU - Patai, Árpád V.

AU - Barták, Barbara Kinga

AU - Péterfia, Bálint

AU - Micsik, Tamás

AU - Horváth, Réka

AU - Sumánszki, Csaba

AU - Péter, Zoltán

AU - Patai, Árpád

AU - Valcz, Gábor

AU - Kalmár, Alexandra

AU - Tóth, Kinga

AU - Krenács, T.

AU - Tulassay, Z.

AU - Molnár, B.

PY - 2016/11/29

Y1 - 2016/11/29

N2 - Colorectal sessile serrated adenomas (SSA) are hypothesized to be precursor lesions of an alternative, serrated pathway of colorectal cancer, abundant in genes with aberrant promoter DNA hypermethylation. In our present pilot study, we explored DNA methylation profiles and examined selected gene mutations in SSA. Biopsy samples from patients undergoing screening colonoscopy were obtained during endoscopic examination. After DNA isolation and quality analysis, SSAs (n = 4) and healthy controls (n = 5) were chosen for further analysis. DNA methylation status of 96 candidate genes was screened by q(RT)PCR using Methyl-Profiler PCR array system. Amplicons for 12 gene mutations were sequenced by GS Junior Instrument using ligated and barcoded adaptors. Analysis of DNA methylation revealed 9 hypermethylated genes in both normal and SSA samples. 12 genes (CALCA, DKK2, GALR2, OPCML, PCDH10, SFRP1, SFRP2, SLIT3, SST, TAC1, VIM, WIF1) were hypermethylated in all SSAs and 2 additional genes (BNC1 and PDLIM4) were hypermethylated in 3 out of 4 SSAs, but in none of the normal samples. 2 SSAs exhibited BRAF mutation and synchronous MLH1 hypermethylation and were microsatellite instable by immunohistochemical analysis. Our combined mutation and DNA methylation analysis revealed that there is a common DNA methylation signature present in pre-neoplastic SSAs. This study advocates for the use of DNA methylation as a potential biomarker for the detection of SSA; however, further investigation is needed to better characterize the molecular background of these newly recognized colorectal lesions.

AB - Colorectal sessile serrated adenomas (SSA) are hypothesized to be precursor lesions of an alternative, serrated pathway of colorectal cancer, abundant in genes with aberrant promoter DNA hypermethylation. In our present pilot study, we explored DNA methylation profiles and examined selected gene mutations in SSA. Biopsy samples from patients undergoing screening colonoscopy were obtained during endoscopic examination. After DNA isolation and quality analysis, SSAs (n = 4) and healthy controls (n = 5) were chosen for further analysis. DNA methylation status of 96 candidate genes was screened by q(RT)PCR using Methyl-Profiler PCR array system. Amplicons for 12 gene mutations were sequenced by GS Junior Instrument using ligated and barcoded adaptors. Analysis of DNA methylation revealed 9 hypermethylated genes in both normal and SSA samples. 12 genes (CALCA, DKK2, GALR2, OPCML, PCDH10, SFRP1, SFRP2, SLIT3, SST, TAC1, VIM, WIF1) were hypermethylated in all SSAs and 2 additional genes (BNC1 and PDLIM4) were hypermethylated in 3 out of 4 SSAs, but in none of the normal samples. 2 SSAs exhibited BRAF mutation and synchronous MLH1 hypermethylation and were microsatellite instable by immunohistochemical analysis. Our combined mutation and DNA methylation analysis revealed that there is a common DNA methylation signature present in pre-neoplastic SSAs. This study advocates for the use of DNA methylation as a potential biomarker for the detection of SSA; however, further investigation is needed to better characterize the molecular background of these newly recognized colorectal lesions.

KW - Biomarker

KW - DNA methylation

KW - Mutation

KW - Serrated polyp

KW - Sessile serrated adenoma

KW - Traditional serrated adenoma

UR - http://www.scopus.com/inward/record.url?scp=84997701195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997701195&partnerID=8YFLogxK

U2 - 10.1007/s12253-016-0154-6

DO - 10.1007/s12253-016-0154-6

M3 - Article

C2 - 27896617

AN - SCOPUS:84997701195

SP - 1

EP - 6

JO - Pathology and Oncology Research

JF - Pathology and Oncology Research

SN - 1219-4956

ER -